Taiwan Liposome Company Ltd Asset Turnover Ratio (TLC), as of fourth quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Taiwan Liposome Company Ltd   (NASDAQ: TLC)
 

Taiwan Liposome Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2020, Taiwan Liposome Ltd 's asset turnover ratio sequentially decreased to 0.06 in the fourth quarter (Dec 31 2020), this is lower than usual.

Within sector 209 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2020 compared to the preceding quarter from 3196 to 3740.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TLC Asset Turnover Ratio (Dec 31 2020)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Asset Change 28.19 % 34.45 % 34.45 % 34.45 % 3.31 %
Y / Y Revenue Change -48.08 % - - - 243.42 %
Asset Turnover Ratio (TTM) 0.06 - - - 0.15
TLC's Total Ranking # 3740 # 3196 # 3724 # 0 # 3967
Seq. Asset Change 0.06 % 0 % 0 % 28.12 % 4.94 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 210
Healthcare Sector # 527
Overall Market # 3740

Asset Turnover Ratio Statistics
High Average Low
1.56 1.04 0.75
(Dec 31 2019)   (Dec 31 2020)




TLC Company Profile • Back to TLC Efficiency Comparisons • Compare TLC Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Assets at quarter ending Dec 31 2020
Rapid Therapeutic Science Laboratories Inc   0.16 $ 0.131  Millions$ 0.820  Millions
Alnylam Pharmaceuticals Inc   0.16 $ 492.853  Millions$ 3,092.084  Millions
Sunshine Biopharma Inc   0.16 $ 0.071  Millions$ 0.450  Millions
Pliant Therapeutics Inc   0.16 $ 41.817  Millions$ 263.929  Millions
Editas Medicine Inc   0.16 $ 90.732  Millions$ 572.994  Millions
Cyclo Therapeutics Inc   0.16 $ 0.903  Millions$ 5.717  Millions
Cellectis S a   0.16 $ 73.949  Millions$ 470.277  Millions
Nutriband Inc   0.15 $ 0.944  Millions$ 6.101  Millions
Regenerx Biopharmaceuticals inc   0.15 $ 0.077  Millions$ 0.499  Millions
Sutro Biopharma Inc   0.15 $ 42.722  Millions$ 283.190  Millions
Remedent Inc   0.15 $ 1.129  Millions$ 7.502  Millions
Cytokinetics Incorporated  0.15 $ 55.828  Millions$ 374.248  Millions
Ligand Pharmaceuticals Incorporated  0.15 $ 186.419  Millions$ 1,259.647  Millions
Arrowhead Pharmaceuticals Inc   0.15 $ 79.840  Millions$ 540.453  Millions
Guardion Health Sciences Inc   0.15 $ 1.890  Millions$ 12.834  Millions
Seres Therapeutics Inc   0.15 $ 33.215  Millions$ 227.610  Millions
Navidea Biopharmaceuticals Inc   0.14 $ 0.915  Millions$ 6.334  Millions
Genocea Biosciences Inc   0.14 $ 10.248  Millions$ 72.600  Millions
Sangamo Therapeutics Inc   0.14 $ 118.192  Millions$ 845.299  Millions
Arcus Biosciences Inc   0.14 $ 77.517  Millions$ 560.225  Millions
Bluebird Bio Inc   0.14 $ 250.734  Millions$ 1,840.908  Millions
Hookipa Pharma inc   0.14 $ 19.584  Millions$ 144.581  Millions
Precision Biosciences Inc  0.14 $ 24.285  Millions$ 179.310  Millions
Curis Inc   0.13 $ 10.835  Millions$ 80.432  Millions
Intelgenx Technologies Corp   0.13 $ 1.544  Millions$ 11.497  Millions
Theravance Biopharma inc   0.13 $ 71.857  Millions$ 537.746  Millions
Xeris Biopharma Holdings Inc   0.13 $ 20.435  Millions$ 152.952  Millions
Therapeutic Solutions International Inc   0.13 $ 0.063  Millions$ 0.472  Millions
Merus N v   0.13 $ 29.943  Millions$ 226.583  Millions
Acceleron Pharma inc  0.13 $ 92.523  Millions$ 705.925  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.